Trials / Completed
CompletedNCT05062408
Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals
Impact of the Sustained Viral Response on the Natural History Chronic Hepatitis c After Treatment With Direct Action Antivirals
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 321 (actual)
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the evolution of liver injury with fibrosis data obtained using non-invasive serological markers in patients who achieved SVR after treatment with direct-acting antivirals.
Detailed description
This open study includes patients with chronic hepatitis C who received treatment with the new direct-acting antivirals between November 1, 2014 and December 31, 2017, who achieved a sustained viral response at week 12.
Conditions
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2021-09-30
- Last updated
- 2021-11-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05062408. Inclusion in this directory is not an endorsement.